These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 37850401)

  • 1. Utility of palliative prognostic index and neutrophil-to-lymphocyte ratio in predicting prognosis of end-stage squamous cell carcinoma of head and neck.
    Higashino M; Sugimoto K; Onishi S; Okabe K; Yasuda C; Tadokoro H; Kawata R
    Head Neck; 2024 Jan; 46(1):23-28. PubMed ID: 37850401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Neutrophil to lymphocyte ratio in peripheral blood: a novel independent prognostic factor in patients with head and neck squamous cell carcinoma].
    Wu F; Wu LL; Zhu LX
    Zhonghua Zhong Liu Za Zhi; 2017 Jan; 39(1):29-32. PubMed ID: 28104030
    [No Abstract]   [Full Text] [Related]  

  • 3. Correlation between preoperative peripheral blood NLR, PLR, LMR and prognosis of patients with head and neck squamous cell carcinoma.
    Zhou J; Wei S; Guo X; Huang Y; Zhang Y; Hong Y; Chen X; Lu M; Zheng F; Zheng C
    BMC Cancer; 2023 Dec; 23(1):1247. PubMed ID: 38110870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neutrophil-to-lymphocyte ratio: Prognostic indicator for head and neck squamous cell carcinoma.
    Rosculet N; Zhou XC; Ha P; Tang M; Levine MA; Neuner G; Califano J
    Head Neck; 2017 Apr; 39(4):662-667. PubMed ID: 28075517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic immune response in squamous cell carcinoma of the head and neck: a comparative concordance index analysis.
    Tham T; Wotman M; Chung C; Ahn S; Dupuis H; Gliagias V; Movsesova T; Kraus D; Costantino P
    Eur Arch Otorhinolaryngol; 2019 Oct; 276(10):2913-2922. PubMed ID: 31312922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the accuracy of clinical prediction of survival and palliative prognostic index for patients with head and neck squamous cell carcinoma in the end-of-life setting.
    Kishino T; Monden N; Akisada N; Hayashi Y; Nakamura M; Hashimoto K; Miyashita T; Mori T; Hoshikawa H
    Auris Nasus Larynx; 2022 Feb; 49(1):133-140. PubMed ID: 34226098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neutrophil-to-lymphocyte ratio as a prognostic marker for head and neck cancer with lung metastasis: a retrospective study.
    Yanni A; Buset T; Bouland C; Loeb I; Lechien JR; Rodriguez A; Journe F; Saussez S; Dequanter D
    Eur Arch Otorhinolaryngol; 2022 Aug; 279(8):4103-4111. PubMed ID: 35099595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High fibrinogen-albumin ratio index (FARI) predicts poor survival in head and neck squamous cell carcinoma patients treated with surgical resection.
    Wang S; Feng Y; Xie Y; Zhao X; Ma J; Liu X; Hu C; Hou T
    Eur Arch Otorhinolaryngol; 2022 Sep; 279(9):4541-4548. PubMed ID: 35462579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Utility of Glasgow Prognostic Score and Palliative Prognostic Index in Patients With Head and Neck Squamous Cell Carcinoma Under Palliative Care.
    Kishino T; Mori T; Miyashita T; Ouchi Y; Samukawa Y; Fukumura T; Takahashi S; Monden N; Akisada N; Hayashi Y; Nakamura M; Hoshikawa H
    Ear Nose Throat J; 2023 Jun; 102(6):379-384. PubMed ID: 33765857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neutrophil-to-lymphocyte ratio as a prognostic indicator for overall and cancer-specific survival in squamous cell carcinoma of the head and neck.
    Ferrandino RM; Roof S; Garneau J; Haidar Y; Bates SE; Park YA; Bauml JM; Genden EM; Miles B; Sigel K
    Head Neck; 2020 Oct; 42(10):2830-2840. PubMed ID: 32592262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relation of baseline neutrophil-to-lymphocyte ratio to survival and toxicity in head and neck cancer patients treated with (chemo-) radiation.
    Bojaxhiu B; Templeton AJ; Elicin O; Shelan M; Zaugg K; Walser M; Giger R; Aebersold DM; Dal Pra A
    Radiat Oncol; 2018 Nov; 13(1):216. PubMed ID: 30400969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic role of neutrophil-to-lymphocyte ratio in head and neck cancer: A meta-analysis.
    Takenaka Y; Oya R; Kitamiura T; Ashida N; Shimizu K; Takemura K; Yamamoto Y; Uno A
    Head Neck; 2018 Mar; 40(3):647-655. PubMed ID: 29076207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel prognostic score based on systemic inflammatory biomarkers for patients with oral squamous cell carcinoma.
    Zhuang Z; Li Y; Hong Y; Chen L; Qian J; Lin J; Chen Q; Qiu Y; Lin L; Shi B; Pan L; Zheng X; Wang J; Liu F; He B; Chen F
    Oral Dis; 2022 Apr; 28(3):631-638. PubMed ID: 33426698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High pretreatment neutrophil-to-lymphocyte ratio as a predictor of poor survival prognosis in head and neck squamous cell carcinoma: Systematic review and meta-analysis.
    Yang L; Huang Y; Zhou L; Dai Y; Hu G
    Head Neck; 2019 May; 41(5):1525-1535. PubMed ID: 30597654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pretreatment count of peripheral neutrophils, monocytes, and lymphocytes as independent prognostic factor in patients with head and neck cancer.
    Valero C; Pardo L; López M; García J; Camacho M; Quer M; León X
    Head Neck; 2017 Feb; 39(2):219-226. PubMed ID: 27534525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neutrophil-to-lymphocyte ratio in head and neck cancer.
    Haddad CR; Guo L; Clarke S; Guminski A; Back M; Eade T
    J Med Imaging Radiat Oncol; 2015 Aug; 59(4):514-519. PubMed ID: 25908427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blood Markers Predicting Clinically Occult Lymph Node Metastasis in Head and Neck Squamous Cell Carcinoma.
    Gaudioso P; Borsetto D; Polesel J; Tirelli G; Emanuelli E; Menegaldo A; Molteni G; Nicolai P; Tomasoni M; Montenegro C; Piazza C; Bossi P; Ciorba A; Canzi P; Giacomarra V; Giudici F; Fussey J; Boscolo-Rizzo P
    ORL J Otorhinolaryngol Relat Spec; 2024; 86(1):32-40. PubMed ID: 37972574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neutrophil-to-lymphocyte ratio as a prognostic marker for head and neck squamous cell carcinoma treated with immune checkpoint inhibitors: Meta-analysis.
    Takenaka Y; Oya R; Takemoto N; Inohara H
    Head Neck; 2022 May; 44(5):1237-1245. PubMed ID: 35146824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic role of neutrophil-to-lymphocyte ratio to laryngeal squamous cell carcinoma: a meta-analysis.
    Zhao Y; Qin J; Qiu Z; Guo J; Chang W
    Braz J Otorhinolaryngol; 2022; 88(5):717-724. PubMed ID: 33272836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic inflammation is an independent predictive marker of clinical outcomes in mucosal squamous cell carcinoma of the head and neck in oropharyngeal and non-oropharyngeal patients.
    Charles KA; Harris BD; Haddad CR; Clarke SJ; Guminski A; Stevens M; Dodds T; Gill AJ; Back M; Veivers D; Eade T
    BMC Cancer; 2016 Feb; 16():124. PubMed ID: 26892430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.